What's new

Human medicines European public assessment report (EPAR): Rizmoic, naldemedine, Date of authorisation: 18/02/2019, Revision: 12, Status: Authorised

Human medicines European public assessment report (EPAR): Rizmoic, naldemedine, Date of authorisation: 18/02/2019, Revision: 12, Status: Authorised

Jun 19, 2025 - 17:45
 0
Human medicines European public assessment report (EPAR): Rizmoic, naldemedine, Date of authorisation: 18/02/2019, Revision: 12, Status: Authorised
Human medicines European public assessment report (EPAR): Rizmoic, naldemedine, Date of authorisation: 18/02/2019, Revision: 12, Status: Authorised
Read More

Tags:

Previous Article

Thailand's $1.2 Billion F1 Race Will Be The Most Expensive Ever

Next Article

RAAF MQ-28A Ghost Bat Teams Up with E-7A Wedgetail AEW&C Aircraft

Related Posts

Human medicines European public assessment report (EPAR): Rivastigmine Actavis, rivastigmine, Date of authorisation: 16/06/2011, Revision: 21, Status: Authorised

Human medicines European public assessment report (EPAR...

Jun 13, 2025  0

Human medicines European public assessment report (EPAR): Sprycel, dasatinib (anhydrous), Date of authorisation: 20/11/2006, Revision: 44, Status: Authorised

Human medicines European public assessment report (EPAR...

May 15, 2025  0

Highlights - Second EMA / Alliance for Regenerative Med...

Jun 5, 2025  0